I've Been Wrong About Philip Morris International Stock for 5 Years. Here's Why I'm Finally Changing My Mind.

It successfully pivoted from declining cigarettes toward higher-growth, higher-margin smoke-free products. Strong second quarter results show that this transformation is turning into solid financial performance.

The Motley Fool • Sep 1, 2026

Philip Morris International to Host Webcast of Fireside Chat Session at Barclays Global Consumer Conference

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live webcast of a fireside chat session with Jacek Olczak, Group CEO PMI, at the 2026 Barclays Global Consumer Conference on Tuesday, September 8, 2026, at approximately 9:45 a.m. ET. The webcast can be accessed here. An archived copy of the webcast will be available for six months post-event on the same page. The webcast can also be accessed on mobile devices by downloading PMI's IR Ap.

Business Wire • Sep 1, 2026

Philip Morris: Big Tobacco With High-Growth Smoke-Free Assets - Premium Price Tag

PM's premium positioning across IQOS (heated), ZYN (nicotine pouches), VEEV One (vape), and Marlboro (cigarettes) underscores their robust pricing power amid uncertain macros. The smoke-free segment, led by ZYN and IQOS, now comprises >41% of revenues, supporting a multi-year asset renewal/adoption runway amid secular combustible decline. Premium valuations are justified by strong FCF, rich dividend growth, and lower debt leverage, with PM likely to announce the next payout hike in September.

Seeking Alpha • Aug 25, 2026

Philip Morris' ZYN ULTRA FDA Authorization Strengthens Smoke-Free Push

PM's FDA authorization for 11 ZYN ULTRA nicotine pouches expands its U.S. smoke-free portfolio and supports the long-term transformation.

Zacks Investment Research • Aug 24, 2026

Altria, Philip Morris International sign contract manufacturing deals

Philip Morris International and Altria said on Monday they had ​entered contract manufacturing arrangements with one another, as ‌Altria looks to grow cigarette imports and exports and take advantage of a tax rebate.

Reuters • Aug 24, 2026

Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency

RICHMOND, Va.--(BUSINESS WIRE)--Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency.

Business Wire • Aug 24, 2026

Philip Morris gets FDA nod for 11 new nicotine pouches

The U.S. Food and Drug Administration said on Friday it had authorized ​11 nicotine pouch products recently launched ‌by Philip Morris , citing lower levels of harmful constituents compared with other oral and smokeless ​tobacco products.

Reuters • Aug 21, 2026

Philip Morris (PM) Up 0.2% Since Last Earnings Report: Can It Continue?

Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Aug 21, 2026

FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI's U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today's action further enhances PMI's leadership role in the smoke-free category. “We are del.

Business Wire • Aug 21, 2026

Can nicotine pouches drive Big Tobacco's future beyond cigarettes?

Fast-growing nicotine pouches have emerged as one of Big Tobacco's most important bets on a future beyond cigarettes, offering rapid growth, attractive margins and, for now, lighter regulation than many ​rival smoking alternatives.

Reuters • Aug 18, 2026